semaglutide weekly injection Shines as Weight Loss Therapy Wegovy Weight Loss Injections |
Description
Conoce los protocolos de Marta Masi para evitar el efecto rebote.
Wegovy is a GLP-1 receptor agonist
N = 161,798 after matching GLP-1RA vs diet/exercise consultation Median follow-up: 2 years Key result: Any obesity-associated cancer HR 0.59, 95% CI 0.53-0.67 Site-specific signals: Multiple myeloma HR 0.37 Pancreatic cancer HR 0.40 Endometrial cancer HR 0.42 Colorectal cancer HR 0.49 But remember: This is observational
GLP3 R3T vskumn peptid s inkom na GIP, GLP-1 a glukagnov receptory
The data are provided by patients and collected by the UK National Health Service as part of their care and support
